BioLife Solutions, Inc.BLFSNASDAQ
Loading
Book Value/Share Growth Recovery in ProgressRecovering
Percentile Rank77
5Y CAGR+0.2%
Year-over-Year Change
Year-over-year book value per share growth
5Y CAGR
+0.2%/yr
Long-term compound
Percentile
P77
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
2 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | 5.51% |
| Q3 2025 | 1.63% |
| Q2 2025 | -2.92% |
| Q1 2025 | 0.02% |
| Q4 2024 | 6.12% |
| Q3 2024 | 0.87% |
| Q2 2024 | -4.79% |
| Q1 2024 | -2.59% |
| Q4 2023 | -1.14% |
| Q3 2023 | -5.99% |
| Q2 2023 | -2.61% |
| Q1 2023 | -2.21% |
| Q4 2022 | -11.09% |
| Q3 2022 | -1.42% |
| Q2 2022 | -14.74% |
| Q1 2022 | -1.27% |
| Q4 2021 | -3.54% |
| Q3 2021 | 0.67% |
| Q2 2021 | 89.12% |
| Q1 2021 | 0.87% |
| Q4 2020 | 5.44% |
| Q3 2020 | 29.96% |
| Q2 2020 | 41.01% |
| Q1 2020 | -19.99% |
| Q4 2019 | 3.28% |
| Q3 2019 | 58.63% |
| Q2 2019 | 3.08% |
| Q1 2019 | 1.78% |
| Q4 2018 | -7.87% |
| Q3 2018 | 96.42% |
| Q2 2018 | 74.33% |
| Q1 2018 | -2.45% |
| Q4 2017 | 39.71% |
| Q3 2017 | 2.30% |
| Q2 2017 | 146.34% |
| Q1 2017 | -12.58% |
| Q4 2016 | -52.31% |
| Q3 2016 | -13.60% |
| Q2 2016 | -12.31% |
| Q1 2016 | -14.55% |